Cancer Institute and Hospital, Chinese Academy of Medical Sciences: Esophageal Neoplasms trials

The registry lists 23 Esophageal Neoplasms studies with Cancer Institute and Hospital, Chinese Academy of Medical Sciences as lead sponsor. 18 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 12Phase 3 4No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Phase II Single-arm Clinical Study in the Treatment of Locally Advanced Esophageal Cancer After Failed Neoadjuvant ChemoimmunotherapyNot yet recruitingNCT07530549Phase 2
• The Application of Symptoms Management Program Based on the Patient Reported Outcome After EsophagectomyRecruitingNCT07187154Not applicable
• Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant TherapyNot yet recruitingNCT06889402
• Goal-directed Enteral Nutritional Perioperative ManagementRecruitingNCT06510543Not applicable
• MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal CancerRecruitingNCT06498752Phase 2
• Neoadjuvant Comprehensive Treatment for Unresectable Esophageal CancerRecruitingNCT06430658Phase 2
• Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer PatientsRecruitingNCT06429839Phase 2
• Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal CancerRecruitingNCT06421376Phase 2
• Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell CarcinomaRecruitingNCT06410651Phase 2
• Camrelizumab Combined With Chemotherapy and Radiotherapy Perioperative Treatment of Esophageal Gastric Junction AdenocarcinomaRecruitingNCT06163729Phase 2
• PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal CancerRecruitingNCT06086457Phase 3
• Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus ChemotherapyRecruitingNCT06084897Phase 2
• Perioperative Analgesia Modes in Minimally Invasive EsophagectomyRecruitingNCT05504265Phase 2/3
• Surgery or Chemoradiotherapy for Cervical Esophageal CancerRecruitingNCT05327517Not applicable
• Neoadjuvant Treatment Modalities in Esophageal CancerRecruitingNCT04821843Phase 3
• Chemoradiotherapy in Esophageal or Esophagogastric Junction CancerRecruitingNCT04821778Phase 3
• Chemoradiotherapy in Unresectable Esophageal CancerRecruitingNCT04278287Phase 1/2
• MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing ChemoradiotherapyRecruitingNCT02988921Not applicable
• Study on the Design and Application of Special Semi Recumbent Cushion for Postoperative Patients With Esophageal CancerCompletedNCT05542680Not applicable
• Mechanical Bowel Preparation Versus no Bowel Preparation for Esophageal Cancer SurgeryCompletedNCT05523960Not applicable
• Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal CancerCompletedNCT04821765Phase 2
• A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal CancerCompletedNCT04207918Phase 2
• Mediastinoscopy-assisted Transhiatal Esophagectomy Versus Thoraco-laparoscopic Esophagectomy for Esophageal CancerStatus unknownNCT04125849Not applicable